{
  "ticker": "CRNX",
  "company_name": "Crinetics Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05192382",
      "title": "A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Acromegaly",
      "start_date": "2021-12-17",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05907291",
      "title": "Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia",
      "start_date": "2023-07-03",
      "completion_date": "2025-08-22",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT04246749",
      "title": "Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2019-09-17",
      "completion_date": "2019-10-25",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT07221084",
      "title": "A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2025-10",
      "completion_date": "2026-02",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT07129252",
      "title": "A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm",
      "start_date": "2025-11-26",
      "completion_date": "2029-08",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05804669",
      "title": "A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome",
      "start_date": "2023-10-12",
      "completion_date": "2026-10",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03789656",
      "title": "An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Acromegaly",
      "start_date": "2019-03-12",
      "completion_date": "2020-08-31",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT07159841",
      "title": "A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)",
      "status": "RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia",
      "start_date": "2026-01-31",
      "completion_date": "2030-03",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03936166",
      "title": "A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2019-04-29",
      "completion_date": "2019-12-16",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT04837040",
      "title": "A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Acromegaly",
      "start_date": "2021-05-12",
      "completion_date": "2027-06",
      "enrollment": 0,
      "sponsor": "Crinetics Pharmaceuticals Inc."
    }
  ],
  "summary": {
    "total_trials": 18,
    "by_phase": {
      "PHASE3": 4,
      "PHASE2": 6,
      "PHASE1": 5,
      "PHASE1, PHASE2": 2,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 4,
      "COMPLETED": 7,
      "RECRUITING": 7
    },
    "active_trials": 11,
    "completed_trials": 7,
    "conditions": [
      "Acromegaly",
      "Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Syndrome Diarrhea, Carcinoid Intestine Tumor, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas",
      "Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas, Carcinoid Syndrome Diarrhea, Carcinoid Intestine Tumor",
      "Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia",
      "Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome",
      "Healthy Volunteers",
      "SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:42.723009",
    "search_query": "Crinetics Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Crinetics+Pharmaceuticals,+Inc."
  }
}